InsidersTradesSigma
NextCell Pharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the NextCell Pharma AB share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has published 3 reports. Market capitalisation: €118.3m. The latest transaction was disclosed on 2 June 2025 (Other). Among the most active insiders: Patrik Fagerholm. The full history is openly available.
3
Insider Decl.
0
Thresholds
€821
1 ops.
Buy Volume
·
0 ops.
Sell Volume
42Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 June 2025
Declarations3 total
298,440 shares@ €0.0920.023% mcap96.7% of flowAktieFI:A003P179-2
1,320 shares@ €0.0920.0001% mcap0.4% of flowAktieFI:A003P178-2
100,000 shares@ €0.00820.0007% mcap2.9% of flowTeckningsoptionFI:A003N606-1
Ideal exit: 23 Jan 2026 (T+270)
3 of 3 declarations